Back to search
HIGH RISK PROSTATE CANCER
Clinical trial pipeline · Data from ClinicalTrials.gov
See which HIGH RISK PROSTATE CANCER trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which HIGH RISK PROSTATE CANCER trials you may qualify forThis phase III trial compares stereotactic body radiation therapy (SBRT), (five treatments over two weeks using a higher dose per treatment) to usual radiation…
This study aims to compare the novel single-port robotic partial prostatectomy to High-intensity focused ultrasound (HIFU) in patients with low to intermediate…
The aim for this study is to assess the diagnostic performance of 64Cu-SAR-bisPSMA PET to detect regional nodal metastases.
The goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic solid tumors.
To learn about the safety and effects of a drug called REGN5678 when it is given to patients with high-risk prostate cancer.
This is a Phase II, single arm, multi-centre, prospective clinical trial evaluating next generation Stereotactic Ablative Radiotherapy (SABR) for low, intermedi…
This is a phase II, multicenter, randomized open-label and comparative trial designed to study the effectiveness and the safety of androgen receptor antagonist…
The purpose of this study is to determine if apalutamide plus gonadotropin releasing hormone (GnRH) agonist in participants with high-risk, localized or locally…